Genome-wide identification of allelic expression in hypertensive rats

Circulation: Cardiovascular Genetics

Volumn 2, Issue 2, 2009, Pages 106-115

  Dmitrieva, Renata I ^a   Hinojos, Cruz A ^a   Grove, Megan L ^b   Bell, Rebecca J ^a   Boerwinkle, Eric ^b   Fornage, Myriam ^a   Doris, Peter A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Candidate genes; Gene array; Gene expression; Genetic hypertension; Haplotype; Kidney; Spontaneously hypertensive rat

Indexed keywords

ALLELE; ARTICLE; BIOINFORMATICS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DAPK 2 GENE; ELA1 GENE; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; GSTT2 GENE; HYPERTENSION; MALE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROGENY; PTPRJ GENE; RAT; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETICS; HUMAN; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PEDIGREE; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALIA; RATTUS;

ALLELES; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; KIDNEY; MALE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 77649215284     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.108.809509     Document Type: Article

References (44)

1. Greenhouse DD, Festing MFW, Hasan S, Cohen AL. Genetic Monitoring of Inbred Strains of Rats. Stuttgart: Gustav Fischer; 1990.
2. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat. Circ Res. 1974; 34/35: I143-I153.
3. Hinojos CA, Boerwinkle E, Fornage M, Doris PA. Combined genealogical, mapping, and expression approaches to identify spontaneously hypertensive rat hypertension candidate genes. Hypertension. 2005; 45: 698-704.
4. Fornage M, Hinojos CA, Nurowska BW, Boerwinkle E, Hammock BD, Morisseau CH, Doris PA. Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats. Hypertension. 2002; 40: 485-490.
5. Fornage M, Swank MW, Boerwinkle E, Doris PA. Gene expression profiling and functional proteomic analysis reveal perturbed kinasemediated signaling in genetic stroke susceptibility. Physiol Genomics. 2003; 15: 75-83.
6. Bray MS, Boerwinkle E, Doris PA. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat. 2001; 17: 296-304.
7. Bray MS, Doris PA. Genotyping by mass spectrometry. Genet Eng (NY). 2003; 25: 1-14.
8. Twigger SN, Pasko D, Nie J, Shimoyama M, Bromberg S, Campbell D, Chen J, dela Cruz N, Fan C, Foote C, Harris G, Hickmann B, Ji Y, Jin W, Li D, Mathis J, Nenasheva N, Nigam R, Petri V, Reilly D, Ruotti V, Schauberger E, Seiler K, Slyper R, Smith J, Wang W, Wu W, Zhao L, Zuniga-Meyer A, Tonellato PJ, Kwitek AE, Jacob HJ. Tools and strategies for physiological genomics: the Rat Genome Database. Physiol Genomics. 2005; 23: 246-256.
9. Gigante B, Rubattu S, Stanzione R, Lombardi A, Baldi A, Baldi F, Volpe M. Contribution of genetic factors to renal lesions in the stroke-prone spontaneously hypertensive rat. Hypertension. 2003; 42: 702-706.
10. Nagaoka A, Iwatsuka H, Suzuoki Z, Okamoto K. Genetic predisposition to stroke in spontaneously hypertensive rats. Am J Physiol. 1976; 230: 1354-1359.
11. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet. 1996; 13: 429-434.
12. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the Am Heart Association council on high blood pressure research. Hypertension. 2005; 45: 299-310.
13. Grisk O, Kloting I, Exner J, Spiess S, Schmidt R, Junghans D, Lorenz G, Rettig R. Long-term arterial pressure in spontaneously hypertensive rats is set by the kidney. J Hypertens. 2002; 20: 131-138.
14. Louis WJ, Howes LG. Genealogy of the spontaneously hypertensive rat and Wistar-Kyoto rat strains: implications for studies of inherited hypertension. J Cardiovasc Pharmacol. 1990; 16 (Suppl 7) : S1-S5.
15. Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, Musilova A, Kren V, Causton H, Game L, Born G, Schmidt S, Muller A, Cook SA, Kurtz TW, Whittaker J, Pravenec M, Aitman TJ. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet. 2005; 37: 243-253.
16. Garrett MR, Meng H, Rapp JP, Joe B. Locating a blood pressure quantitative trait locus within 117 kb on the rat genome: substitution mapping and renal expression analysis. Hypertension. 2005; 45: 451-459.
17. Joe B, Letwin NE, Garrett MR, Dhindaw S, Frank B, Sultana R, Verratti K, Rapp JP, Lee NH. Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array. Physiol Genomics. 2005; 23: 318-326.
18. McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, Charchar FJ, Brosnan MJ, Dominiczak AF. Microarray analysis of rat chromosome 2 congenic strains. Hypertension. 2003; 41: 847-853.
19. Moujahidine M, Lambert R, Dutil J, Palijan A, Sivo Z, Ariyarajah A, Deng AY. Combining congenic coverage with gene profiling in search of candidates for blood pressure quantitative trait loci in Dahl rats. Hypertens Res. 2004; 27: 203-212.
20. Yagil Y, Yagil C. Insights into pharmacogenomics and its impact upon immunosuppressive therapy. Transpl Immunol. 2002; 9: 203-209.
21. Iwai N, Inagami T. Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension. 1991; 17: 161-169.
22. Nabika T, Kobayashi Y, Yamori Y. Congenic rats for hypertension: how useful are they for the hunting of hypertension genes? Clin Exp Pharmacol Physiol. 2000; 27: 251-256.
23. Kovacs P, Voigt B, Kloting I. Novel quantitative trait loci for blood pressure and related traits on rat chromosomes 1, 10, and 18. Biochem Biophys Res Commun. 1997; 235: 343-348.
24. St Lezin E, Liu W, Wang JM, Wang N, Kren V, Krenova D, Musilova A, Zdobinska M, Zidek V, Lau D, Pravenec M. Genetic isolation of a chromosome 1 region affecting blood pressure in the spontaneously hypertensive rat. Hypertension. 1997; 30: 854-859.
25. Frantz S, Clemitson JR, Bihoreau MT, Gauguier D, Samani NJ. Genetic dissection of region around the Sa gene on rat chromosome 1: evidence for multiple loci affecting blood pressure. Hypertension. 2001; 38: 216-221.
26. Lindpaintner K, Hilbert P, Ganten D, Nadal-Ginard B, Inagami T, Iwai N. Molecular genetics of the Sa-gene: cosegregation with hypertension and mapping to rat chromosome 1. J Hypertens. 1993; 11: 19-23.
27. Frantz SA, Thiara AS, Lodwick D, Samani NJ. A major polymorphism in the rat SA gene caused by the insertion of a LINE element. Mamm Genome. 1996; 7: 865-866.
28. Kaiser MA, Lodwick D, Samani NJ. The rat SA gene shows genotypedependent tissue-specific expression. Clin Sci (Lond). 1994; 87: 1-4.
29. Iwai N, Katsuya T, Mannami T, Higaki J, Ogihara T, Kokame K, Ogata J, Baba S. Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension. Circulation. 2002; 105: 41-47.
30. Iwai N, Ohmichi N, Hanai K, Nakamura Y, Kinoshita M. Human SA gene locus as a candidate locus for essential hypertension. Hypertension. 1994; 23: 375-380.
31. Narita I, Saito N, Goto S, Shirasaki A, Morioka Y, Jin S, Omori K, Sakatsume M, Arakawa M, Gejyo F. Role of genetic polymorphism in the SA gene on the blood pressure and prognosis of renal function in patients with immunoglobulin A nephropathy. Hypertens Res. 2002; 25: 831-836.
32. St Lezin E, Liu W, Wang JM, Yang Y, Qi N, Kren V, Zidek V, Kurtz TW, Pravenec M. Genetic analysis of rat chromosome 1 and the Sa gene in spontaneous hypertension. Hypertension. 2000; 35: 225-230.
33. Hubner N, Lee YA, Lindpaintner K, Ganten D, Kreutz R. Congenic substitution mapping excludes Sa as a candidate gene locus for a blood pressure quantitative trait locus on rat chromosome 1. Hypertension. 1999; 34: 643-648.
34. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, Zeldin DC, Kroetz DL. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res. 2000; 87: 992-998.
35. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenasederived eicosanoids. Science (NY). 1999; 285: 1276-1279.
36. Spiecker M, Liao JK. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys. 2005; 433: 413-420.
37. Fornage M, Boerwinkle E, Doris PA, Jacobs D, Liu K, Wong ND. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: the coronary artery risk development in young adults (CARDIA) study. Circulation. 2004; 109: 335-339.
38. Fornage M, Lee CR, Doris PA, Bray MS, Heiss G, Zeldin DC, Boerwinkle E. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke. Hum Mol Genet. 2005; 14: 2829-2837.
39. Wei Q, Doris PA, Pollizotto MV, Boerwinkle E, Jacobs DR Jr, Siscovick DS, Fornage M. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking. Atherosclerosis. 2007; 190: 26-34.
40. Arking DE, Becker DM, Yanek LR, Fallin D, Judge DP, Moy TF, Becker LC, Dietz HC. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet. 2003; 72: 1154-1161.
41. Blankenberg S, Godefroy T, Poirier O, Rupprecht HJ, Barbaux S, Bickel C, Nicaud V, Schnabel R, Kee F, Morrison C, Evans A, Lackner KJ, Cambien F, Munzel T, Tiret L. Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk. Circ Res. 2006; 99: 102-108.
42. Pastinen T, Ge B, Gurd S, Gaudin T, Dore C, Lemire M, Lepage P, Harmsen E, Hudson TJ. Mapping common regulatory variants to human haplotypes. Hum Mol Genet. 2005; 14: 3963-3971.
43. Poon AH, Laprise C, Lemire M, Montpetit A, Sinnett D, Schurr E, Hudson TJ. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med. 2004; 170: 967-973.
44. Pravenec M, Churchill PC, Churchill MC, Viklicky O, Kazdova L, Aitman TJ, Petretto E, Hubner N, Wallace CA, Zimdahl H, Zidek V, Landa V, Dunbar J, Bidani A, Griffin K, Qi N, Maxova M, Kren V, Mlejnek P, Wang J, Kurtz TW. Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nat Genet. 2008